MCS-18, a novel natural plant product prevents autoimmune diabetes

Immunology Letters

Volumn 139, Issue 1-2, 2011, Pages 58-67

  Seifarth, Christian ^a,c   Littmann, Leonie ^a   Resheq, Yazid ^a   Rössner, Susanne ^a   Goldwich, Andreas ^a   Pangratz, Nadine ^a   Kerek, Franz ^b   Steinkasserer, Alexander ^a   Zinser, Elisabeth ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b DoNatur GmbH   (Germany)

^c Practice for Endocrinology   (Germany)

Author keywords

Autoimmunity; Diabetes; Regulatory T cells

Indexed keywords

ANTIDIABETIC AGENT; GAMMA INTERFERON; MCS 18; PLANT EXTRACT; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG MEGADOSE; GENE DOSAGE; HELLEBORUS PURPURASCENS; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT RESPONSE; VERATRUM;

ANIMALS; BIOLOGICAL AGENTS; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INTERFERON-GAMMA; ISLETS OF LANGERHANS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 79960697392     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.04.016     Document Type: Article

References (36)

1. Castano L., Eisenbarth G.S. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990, 8:647-679.
2. Delovitch T.L., Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997, 7:727-738.
3. Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996, 85:291-297.
4. Haskins K., Wegmann D. Diabetogenic T-cell clones. Diabetes 1996, 45:1299-1305.
5. Wang B., Gonzalez A., Benoist C., Mathis D. The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 1996, 26:1762-1769.
6. Feili-Hariri M., Flores R.R., Vasquez A.C., Morel P.A. Dendritic cell immunotherapy for autoimmune diabetes. Immunol Res 2006, 36:167-173.
7. Atkinson M.A., Leiter E.H. The NOD mouse model of type 1 diabetes: as good as it gets?. Nat Med 1999, 5:601-604.
8. Herold K.C., Hagopian W., Auger J.A., Poumian-Ruiz E., Taylor L., Donaldson D., et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002, 346:1692-1698.
9. Keymeulen B., Vandemeulebroucke E., Ziegler A.G., Mathieu C., Kaufman L., Hale G., et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005, 352:2598-2608.
10. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002, 346:1685-1691.
11. Kim M.S., Polychronakos C. Immunogenetics of type 1 diabetes. Horm Res 2005, 64:180-188.
12. Maier L.M., Wicker L.S. Genetic susceptibility to type 1 diabetes. Curr Opin Immunol 2005, 17:601-608.
13. Achenbach P., Warncke K., Reiter J., Williams A.J., Ziegler A.G., Bingley P.J., et al. Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives. Diabetologia 2006, 49:2969-2976.
14. Schlosser M., Koczwara K., Kenk H., Strebelow M., Rjasanowski I., Wassmuth R., et al. In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk. Diabetologia 2005, 48:1830-1832.
15. Horstmann B., Zinser E., Turza N., Kerek F., Steinkasserer A. MCS-18, a novel natural product isolated from Helleborus purpurascens, inhibits dendritic cell activation and prevents autoimmunity as shown in vivo using the EAE model. Immunobiology 2007, 212:839-853.
16. Littmann L., Rossner S., Kerek F., Steinkasserer A., Zinser E. Modulation of murine bone marrow-derived dendritic cells and B-cells by MCS-18 a natural product isolated from Helleborus purpurascens. Immunobiology 2008, 213:871-878.
17. Kerek F., Szegli G., Cremer L., Lupu A.R., Durbaca S., Calugaru A., et al. The novel arthritis-drug substance MCS-18 attenuates the antibody production in vivo. Acta Microbiol Immunol Hung 2008, 55:15-31.
18. Nica S., Stanescu L., Krejci G. A randomised doubleblind phase II study with injection containing MCS-18 as active substance in 3+1 doses versus placebo in the treatment of painfull shoulder periarthritis. Clin Trial Rep 2005, 1-216.
19. Anderson B., Park B.J., Verdaguer J., Amrani A., Santamaria P. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes. Proc Natl Acad Sci USA 1999, 96:9311-9316.
20. Amrani A., Verdaguer J., Serra P., Tafuro S., Tan R., Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 2000, 406:739-742.
21. Brode S., Raine T., Zaccone P., Cooke A. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 2006, 177:6603-6612.
22. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999, 223:77-92.
23. Steptoe R.J., Ritchie J.M., Harrison L.C. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice. J Immunol 2002, 168:5032-5041.
24. Weaver D.J., Liu B., Tisch R. Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice. J Immunol 2001, 167:586-592.
25. Nikolic T., Geutskens S.B., van R.N., Drexhage H.A., Leenen P.J. Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study. Lab Invest 2005, 85:487-501.
26. Spatz M., Eibl N., Hink S., Wolf H.M., Fischer G.F., Mayr W.R., et al. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cell Immunol 2003, 221:15-26.
27. Takahashi K., Honeyman M.C., Harrison L.C. Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J Immunol 1998, 161:2629-2635.
28. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
29. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol 2002, 23:445-449.
30. Tang Q., Henriksen K.J., Boden E.K., Tooley A.J., Ye J., Subudhi S.K., et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol 2003, 171:3348-3352.
31. Chen Z., Herman A.E., Matos M., Mathis D., Benoist C. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med 2005, 202:1387-1397.
32. Machen J., Harnaha J., Lakomy R., Styche A., Trucco M., Giannoukakis N. Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells. J Immunol 2004, 173:4331-4341.
33. Cheatem D., Ganesh B.B., Gangi E., Vasu C., Prabhakar B.S. Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function. Clin Immunol 2009, 131:260-270.
34. Cederbom L., Hall H., Ivars F. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000, 30:1538-1543.
35. Kim J.M., Rasmussen J.P., Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007, 8:191-197.
36. Tritt M., Sgouroudis E., d'Hennezel E., Albanese A., Piccirillo C.A. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 2008, 57:113-123.